Impact of the COVID-19 Pandemic on Medication Adherence and Maintenance Treatment for Schizophrenia: A Reconsideration [Letter]
Yoshiyo Oguchi Department of Neuropsychiatry, St. Marianna University School of Medicine, Kawasaki, JapanCorrespondence: Yoshiyo Oguchi, Department of Neuropsychiatry, St. Marianna University School of Medicine, 2-16-1, Sugao Miyamae-ku, Kawasaki, Kanagawa, 216-8511, Japan, Tel/Fax +81-44-977-8111 E...
Main Author: | Oguchi Y |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-12-01
|
Series: | Neuropsychiatric Disease and Treatment |
Online Access: | https://www.dovepress.com/impact-of-the-covid-19-pandemic-on-medication-adherence-and-maintenanc-peer-reviewed-fulltext-article-NDT |
Similar Items
-
Long‐acting injectable antipsychotics as maintenance therapy for schizophrenia during the COVID‐19 pandemic: A micro‐narrative review
by: Yoshiyo Oguchi, et al.
Published: (2024-03-01) -
Impact of insight quality on treatment adherence in schizophrenia
by: A. Rami, et al.
Published: (2023-03-01) -
Long COVID-19 and Peripheral Serotonin: A Commentary and Reconsideration
by: Anderson GM, et al.
Published: (2024-04-01) -
Effect of the COVID-19 pandemic on medication adherence in psychiatric disorders
by: Bahadir Demir, et al.
Published: (2021-09-01) -
Efficacy of a Smartphone App in Enhancing Medication Adherence and Accuracy in Individuals With Schizophrenia During the COVID-19 Pandemic: Randomized Controlled Trial
by: Huan Hwa Chen, et al.
Published: (2023-12-01)